Literature DB >> 12609662

Spectrophotometric and chromatographic determination of rabeprazole in presence of its degradation products.

Alaa El-Gindy1, Fawzy El-Yazby, Moustafa M Maher.   

Abstract

Three methods were presented for the determination of rabeprazole (RA) in presence of its degradation products. The first method was based on high performance liquid chromatographic (HPLC) separation of RA from its degradation products on a reversed phase, ODS column using a mobile phase of methanol-water (70:30, v/v) and UV detection at 284 nm. The second method was based on HPTLC separation followed by densitometric measurement of the spots at 284 nm. The separation was carried out on Merck HPTLC sheets of silica gel 60 F 254, using acetone-toluene-methanol (9:9:0.6 v/v) as mobile phase. The third method depends on first derivative of the ratio spectra (1DD) by measurement of the amplitudes at 310.2 nm. Moreover, the proposed HPLC method was utilized to investigate the kinetics of the oxidative and photo degradation processes. The pH-rate profile of degradation of RA in Britton-Robinson buffer solutions within the pH range 3-11 was studied. In addition, the activation energy of RA degradation was calculated in Britton-Robinson buffer solution pH 7.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609662     DOI: 10.1016/s0731-7085(02)00445-4

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  8 in total

1.  Quantitative estimation of itopride hydrochloride and rabeprazole sodium from capsule formulation.

Authors:  S Pillai; I Singhvi
Journal:  Indian J Pharm Sci       Date:  2008-09       Impact factor: 0.975

2.  Development and Validation of a UPLC Method by the QbD-Approach for the Estimation of Rabeprazole and Levosulpiride from Capsules.

Authors:  Veera Raghava Raju Thummala; Raja Kumar Seshadri; Satya Sankarsana Jagan Mohan Tharlapu; Mrutyunjaya Rao Ivaturi; Someswara Rao Nittala
Journal:  Sci Pharm       Date:  2014-01-16

3.  Stability-indicating HPLC-DAD methods for determination of two binary mixtures: Rabeprazole sodium-mosapride citrate and rabeprazole sodium-itopride hydrochloride.

Authors:  Hamed M El-Fatatry; Mokhtar M Mabrouk; Ismail I Hewala; Ehab H Emam
Journal:  J Pharm Anal       Date:  2013-09-23

4.  Spectrophotometric determination of certain benzimidazole proton pump inhibitors.

Authors:  A A Syed; Ayesha Syeda
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

5.  Validation and application of a new reversed phase HPLC method for in vitro dissolution studies of rabeprazole sodium in delayed-release tablets.

Authors:  Md Saddam Nawaz
Journal:  J Anal Methods Chem       Date:  2013-08-22       Impact factor: 2.193

6.  A Validated HPTLC Method for Determination of Ondansetron in Combination with Omeprazole or Rabeprazole in Solid Dosage Form.

Authors:  P B Raval; Manisha Puranik; S J Wadher; P G Yeole
Journal:  Indian J Pharm Sci       Date:  2008 May-Jun       Impact factor: 0.975

7.  Development and validation of dissolution testings in acidic media for rabeprazole sodium delayed-release capsules.

Authors:  Yinhe Tan; Xiaoqing Si; Lulu Zhong; Xin Feng; Xinmin Yang; Min Huang; Chuanbin Wu
Journal:  Drug Dev Ind Pharm       Date:  2016-04-11       Impact factor: 3.225

8.  Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography.

Authors:  Senthamil Selvan Perumal; Sanmuga Priya Ekambaram; Samundeswari Raja
Journal:  J Food Drug Anal       Date:  2014-10-28       Impact factor: 6.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.